Depreciation of Elicio Therapeutics, Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Elicio Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Elicio Therapeutics, Inc. Depreciation for the quarter ending 30 Sep 2025 was $100,000.
  • Elicio Therapeutics, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $392,000.
  • Elicio Therapeutics, Inc. annual Depreciation for 2024 was $321,000, a 16% decline from 2023.
  • Elicio Therapeutics, Inc. annual Depreciation for 2023 was $382,000, a 2.1% decline from 2022.
  • Elicio Therapeutics, Inc. annual Depreciation for 2022 was $390,000, a 329% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Elicio Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $392,000 $100,000 +$100,000 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $292,000 $100,000 $0 0% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $292,000 $53,000 -$29,000 -35% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $321,000 $139,000 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $0 $0 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $100,000 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $82,000 -$28,000 -25% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q3 2023 $0 -$100,000 -100% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q1 2023 $110,000 +$78,000 +244% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q3 2022 $100,000 +$77,000 +335% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q1 2022 $117,000 $32,000 +$26,000 +433% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $91,000 $39,000 +$62,000 01 Oct 2021 31 Dec 2021 10-K 17 Mar 2023 2022 FY
Q3 2021 $29,000 $23,000 -$24,000 -51% 01 Jul 2021 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $53,000 $23,000 -$24,000 -51% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $77,000 $6,000 -$21,000 -78% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $98,000 $23,000 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $47,000 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $47,000 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $27,000 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1

Elicio Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $321,000 -$61,000 -16% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $382,000 -$8,000 -2.1% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $390,000 +$299,000 +329% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
2021 $91,000 -$7,000 -7.1% 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023 2022 FY
2020 $98,000 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.